Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes-Reference-Cited by-同舟云学术

Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes

Published:2013-06-25 Issue:6 Volume:8 Page:e66243
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ribeiro Enilze,Ganzinelli Monica,Andreis Daniele,Bertoni Ramona,Giardini Roberto,Fox Stephen B.,Broggini Massimo,Bottini Alberto,Zanoni Vanessa,Bazzola Letizia,Foroni Chiara,Generali Daniele,Damia Giovanna

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Directed therapy of subtypes of triple-negative breast cancer;LA Carey;Oncologist,2011

2. Triple-negative breast cancer: an unmet medical need;CA Hudis;Oncologist,2011

3. Characteristics of triple-negative breast cancer;TC de Ruijter;J Cancer Res Clin Oncol,2011

4. Triple-negative breast cancer;RD Chacon;Breast Cancer Res,2010

5. Molecular stratification of triple-negative breast cancers;CM Perou;Oncologist,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico analysis of the wild-type and mutant-type of BRCA2 gene;Journal of Translational Medicine;2024-05-21

2. Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing;Clinical Journal of Gastroenterology;2023-11-07

3. Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer;Current Issues in Molecular Biology;2022-11-23

4. Role of Chk1 gene in molecular classification and prognosis of gastric cancer using immunohistochemistry and LORD-Q assay;Future Oncology;2022-08

5. Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress;Expert Opinion on Therapeutic Targets;2022-06-03